1.Selective Lipolysis: Its primary and most significant feature is the direct stimulation of lipolysis (fat breakdown) in adipocytes (fat cells), particularly visceral and stubborn subcutaneous fat. It achieves this by:
○Enhancing Hormone-Sensitive Lipase (HSL) Activity: HSL is the key enzyme responsible for breaking down stored triglycerides into free fatty acids (FFAs) for energy.
○Beta-3 Adrenergic Receptor Agonism: It stimulates these receptors on fat cells, further promoting fat breakdown and inhibiting fat storage.
○Suppressing Lipogenesis: It may help reduce the creation of new fat stores.
2.Minimal Anabolic/Mitogenic Activity: Crucially, it lacks the strong binding affinity to growth hormone receptors responsible for IGF-1 production and the subsequent muscle, bone, and organ growth effects. This is its defining safety advantage over full HGH.
3.Improved Insulin Sensitivity: Unlike full HGH which can cause insulin resistance, Fragment 176-191 has been shown in studies to improve insulin sensitivity or have a neutral effect. This makes it potentially more compatible with muscle-building diets and reduces diabetes risk concerns.
4.Reduced Side Effect Profile: By avoiding IGF-1 elevation and significant impact on blood sugar regulation, it sidesteps the major side effects of full HGH (carpal tunnel, joint pain, organ enlargement, significant water retention, severe insulin resistance).
5.Micro-Dosing: Effective doses are measured in micrograms (mcg), significantly lower than milligram (mg) doses of many other compounds. A 2mg vial represents multiple doses.
6.Administration: Requires subcutaneous injection, typically reconstituted with Bacteriostatic Water.
Email: amyraws195@gmail.com
Whatsapp/Telegram: +852 56445864
https://www.giantrawsource.com/peptides/peptides-176-191-fragment-hgh.html
